ORAL COMMUNICATIONS. DEFENCE DAY 07/02/2024 FROM 09:45-11:00. SESSION 1: CLINICAL PROTEOMICS
1. MAPPING EARLY SERUM PROTEOME SIGNATURES OF LIVER REGENERATION IN LIVING DONOR LIVER TRANSPLANT CASES. Lorena Carmona, Matías Ávila, Daniel López y Fernando Corrales.
2. EXPLORING POST-TRANSLATIONAL MODIFICATIONS IN ATHEROSCLEROTIC PLAQUE REGRESSION. David del Rio Aledo, Estefanía Núñez, Paula Nogales, Inmaculada Jorge, Cristina Amparo Devesa, Andrea Laguillo, Rafael Barrero, Jose Manuel Rodríguez, Jacob Fog Bentzon y Jesús Vázquez.
3. A TRANSLATIONAL, HIGH-THROUGHPUT PROTEOMICS PLATFORM FOR THE DEEP ANALYSIS OF PLASMA SAMPLES. Estefanía Núñez, Enrique Calvo, Elena Bonzón-Kulichenko, Ricardo Ponce, Fernando García-Marqués, María Gómez-Serrano, Rocío Campo, Ricardo Magni, Leticia Fernández-Friera, Antonio Fernández-Ortiz, Borja Ibañez y Jesús Vázquez.
4. STRATIFICATION OF EARLY RHEUMATOID ARTHRITIS PATIENTS BY SYNOVIAL PATHOTYPE BASED ON CIRCULATING PROTEIN BIOMARKERS. Rocio Paz Gonzalez, Florencia Picchi, Patricia Fernández Puente, Lucia Lourido, Valentina Calamia, Patricia Quaranta Diaz, Pablo Dominguez Guerrero, Rebeca Hands, Conrad Bessant, Constantino Pitzalis, Francisco J Blanco y Cristina Ruiz Romero.
5. PROTEOMIC ANALYSIS OF PLASMA-DERIVED EXTRACELLULAR VESICLES HELPS TO CHARACTERIZE THE BEST ISOLATION METHOD FOR FUNCTIONAL STUDIES. Eva María Fernández-Sáez, Sara Troitiño, Sofía Pérez-Espinazo, Susana B. Bravo y Ángel García.
ORAL COMMUNICATIONS. DEFENCE DAY 07/02/2024 FROM 12:00-13:00. SESSION 1: CLINICAL PROTEOMICS
6. ANALYSIS OF A NEW HEALTH CRISIS: METAPROTEOMICS TO STUDY LONG COVID. Carmen García-Durán, Leticia Gómez Artiguez, Samuel De la Cámara, Inés Zapico, Maria Luisa Hernáez, Patricia Marín-García, Isabel Azcárate, Alba González-Escalada, Javier Arroyo, Lucía Monteoliva y Concha Gil.
7. GLOBAL REMODELING OF THE PROTEOME IN TERMINAL DIFFERENTIATION. Miguel A Prado, Starr Jiang, Bryan Seguinot, Paul J Schmidt, Qiu Wu, Joao A Paulo, Allon M Klein, Mark D Fleming, Steven P Gygi y Daniel Finley.
8. CHRONIC TREATMENT WITH D2-ANTAGONIST HALOPERIDOL LEADS TO INHIBITORY/EXCITATORY IMBALANCE IN STRIATAL D1-NEURONS. Cátia Santa, Diana Rodrigues, Joana Coelho, Sandra Anjo, Vera M. Mendes, Diogo Bessa-Neto, Michael Dunn, David Cotter, Graca Baltazar, Patricia Monteiro y Bruno Manadas.
49. PROTEOMICS ANALYSES OF OCULAR EXTRACELULAR VESICLES. Raquel Rejas-González, Ana Montero-Calle, Natalia Pastora-Salvador, María José Crespo-Carballés, Emma Ausín-González, Juan Sánchez-Naves, Rodrigo Barderas y Ana Guzmán-Aranguez.
ORAL COMMUNICATIONS. DEFENCE DAY 07/02/2024 FROM 16:45-17:30. SESSION 2: SPATIAL-OMICS: NEW FRONTIERS
9. PUSHING THE LIMITS OF ATMOSPHERIC PRESSURE MALDI MASS SPECTROMETRY HISTOCHEMISTRY (MSHC) ON HIGH-RESOLUTION ORBITRAP SYSTEMS FOR FFPE BIOBANKED TISSUE ANALYSIS. Peter Verhaert, Raf Sciot, Marthe Verhaert, Dick Swaab y Gilles Frache.
10. FUNCTIONAL PROTEOMICS CHARACTERIZATION OF TMOD2 IN COLORECTAL CANCER FORMATION AND PROGRESSION. Ana Montero-Calle, Sofía Jiménez de Ocaña, Raquel Rejas González, Javier Martínez-Useros, María Jesús Fernández-Aceñero, Alberto Peláez-García y Rodrigo Barderas.
11. PROXIMITY LABELING REVEALS COMPLEXES ASSISTING SARS-COV-2 MEMBRANE PROTEIN BIOGENESIS IN THE ER. Juan Ortiz-Mateu, Guy Pearson, Jeremy Carlton, Luis Martínez-Gil, María Jesús García-Murria, Ismael Mingarro y Manuel M. Sánchez del Pino.
ORAL COMMUNICATIONS. DEFENCE DAY 08/02/2024 FROM 09:45-11:00. SESSION 3: NEW ADVANCES IN QUANTITATIVE PROTEOMICS
12. FUNCTIONAL PROTEOMICS CHARACTERIZATION OF THE ROLE OF NCDN IN COLORECTAL CANCER FORMATION AND LIVER METASTASIS. María Garranzo-Asensio, Elisa Carral-Ibarra, Ana Montero-Calle, Javier Martínez-Useros, María Jesús Fernández-Aceñero y Rodrigo Barderas.
32. IN-DEPTH PROTEOMICS ANALYSIS OF PARAFFIN-EMBEDDED TISSUE SAMPLES FROM COLORECTAL CANCER PATIENTS REVEALED NOVEL KEY PROTEINS FOR THE STUDY OF THE DISEASE. Ana Montero-Calle, María Garranzo-Asensio, Vivian de los Ríos, Alberto Peláez-García, María Jesús Fernández-Aceñero, Javier Martínez-USeros y Rodrigo Barderas.
14. USE OF PROTEOMICS TO REVEAL POTENTIAL MARKERS AND CELLULAR PATHWAYS ALTERED IN PSEUDOMYXOMA PERITONEI. Melissa Granados-Rodríguez, Mari C. Vázquez-Borrego, Florina Iulia Bura, Blanca Rufián-Andújar, Lidia Rodríguez-Ortiz, María Torres-Martínez, Ana Moreno-Serrano, Laura Morón-Márquez, Carmen Michán, José Alhama, Álvaro Arjona-Sánchez y Antonio Romero-Ruiz.
15. SHOTGUN STUDY REVEALS SENOMORPHIC TARGETS BASED ON SASP MEDIATED BY SEV. Sergio Lucio-Gallego, Rocío Mato-Basalo, Carmen Alarcón-Veleiro, Lama Berjawi, Ismael López-Calvo, Mónica Carrera, Lola Gutiérrez, Concha Gil, Jesús Mateos, María C Arufe y Juan A Fafián-Labora.
16. DIAPASEF METHODS OPTIMIZATION FOR ROBUST BIOMARKER DISCOVERY. Jeewan Babu Rijal, Christine Schaeffer, Christine Carapito, Imane Charmarke Askar y Dominique Bagnard.
ORAL COMMUNICATIONS. DEFENCE DAY 08/02/2024 FROM 12:30-14:00. SESSION 4: PROTEOMICS OF NON-MODEL ORGANISMS OF INTEREST IN THE AGROFORESTRY, FOOD, AND ENVIRONMENTAL SECTORS
17. A NEW PRM-BASED TARGETED PROTEOMICS METHOD FOR THE QUALITATIVE AND QUANTITATIVE ANALYSIS OF THE DIFFERENT TYPES OF MILK USED IN MIXED-MILK CHEESES. Laura Guerrero, Jose Ramón Lamas, Pedro Razquin, Luis Mata, Fernando Corrales y Alberto Paradela.
18. PROTEOMIC APPROACH TO ANEMONIA SULCATA AND ITS SYMBIONT AS SOURCE OF CLIMATE CHANGE BIOMARKERS AND NEW BIOACTIVE COMPOUNDS. ALMUDENA ESCOBAR NIÑO. Ana Maria Melendez Perez, Rafael Carrasco Reinado, Laura Martin Diaz y Francisco Javier Fernandez Acero.
19. DEVELOPMENT OF PROTEIN BASED MOLECULAR TOOLS TO ENHANCE POPULATION CONNECTIVITY IN THE IBERIAN LYNX (LYNX PARDINUS). Elisa María Espinosa-López, Beatriz Ortiz-Guisado, Javier Alijo-Carmona, Marta Benítez-Funez, Carlos Fuentes-Almagro, Mark Prescott, Philip Brownridge, Robert Beynon, Jesús Diez y Guadalupe Gómez-Baena.
20. WHAT CAN WE LEARN FROM WASTEWATER? Ester Sánchez Jiménez, Carlos Pérez López, Antoni Ginebreda, Joaquin Abian, Damià Barceló y Montserrat Carrascal.
21. QUANTITATIVE PROTEOMIC ANALYSIS OF PSEUDOMONAS PSEUDOALCALIGENES CECT 5344 IN RESPONSE TO CYANIDE, ARSENIC AND MERCURY. Karolina Angelika Bie??o, Alfonso Olaya-Abril, Purificación Cabello, Gema Rodríguez-Caballero, Lara P. Sáez, Víctor M. Luque-Almagro, María Dolores Roldán y Conrado Moreno-Vivián.
98. PROTEOMIC STUDY OF THE EFFECT OF THE BIOSTIMULANTS BTH AND METHYL-JASMONATE ON THE HOLM OAK (QUERCUS ILEX L.) RESPONSE TO PHYTOPHTHORA CINNAMOMI, A CAUSAL AGENT OF THE DECLINE SYNDROME. Marina Muñoz Triviño, Ana María Maldonado Alconada, María Dolores Rey Santomé, Jesús V Jorrín Novo y María Ángeles Castillejo Sánchez.
ORAL COMMUNICATIONS. DEFENCE DAY 08/02/2024 FROM 16:45-18:00. SESSION 5: BIOINFORMATICS AND DATA PROCESSING
22. NEUROPATHOLOGICAL STAGE-DEPENDENT PROTEOME MAPPING OF THE OLFACTORY TRACT IN ALZHEIMER?S DISEASE: FROM EARLY OLFACTORY-RELATED OMICS SIGNATURES TO COMPUTATIONAL REPURPOSING OF DRUG CANDIDATES. Paz Cartas-Cejudo, Adriana Cortés, Mercedes Lachén-Montes, Elena Anaya-Cubero, Elena Puerta, Maite Solas, Joaquín Fernández-Irigoyen y Enrique Santamaría.
23. OPTIMIZED MS/MS DATA PROCESSING TO CONFIDENTLY IDENTIFY THE WEALTH OF LYSINE MODIFICATIONS OCCURRING IN HISTONES. Julie Manessier, Hassan Hijazi, Marie Courçon, Sabine Brugiere, Anne-Marie Hesse, Christophe Bruley y Delphine Pflieger.
24. PROTEOMARKER: AN EASY-TO-USE TOOL TO PROCESS, ANALYZE AND DETECT BIOMARKERS FROM TMT PROTEOMICS DATA. Patricia Martínez-Botía, Pablo Bousquets-Muñoz, Raúl Fernández Pérez y Laura Gutiérrez.
25. TURBOOMICS: A WEB-BASED PLATFORM FOR THE INTEGRATION OF PROTEOMICS AND METABOLOMICS DATA. Rafael Barrero-Rodríguez, Jose Manuel Rodriguez, Annalaura Mastrangelo, Alessia Ferrarini y Jesús Vázquez.
26. A PROTEIN PROBABILITY ALGORITHM USING SHARED PEPTIDES. IMPLICATION FOR PROTEIN QUANTIFICATION. Víctor M. Guerrero-Sánchez, Enrique Calvo, Jose Manuel Rodríguez y Jesús Vázquez.
ORAL COMMUNICATIONS. DEFENCE DAY 09/02/2024 FROM 10:40-11:00. SESSION 6: TOPDOWN & INTERACTOMICS
27. BIOE3: A BIOTIN-BASED PROTEOMICS STRATEGY TO IDENTIFY SPECIFIC SUBSTRATES OF UBIQUITIN E3 LIGASES. Orhi Barroso-Gomila, Laura Merino-Cacho, Veronica Muratore, Elena Maspero, Mikel Azkargorta, Ibon Iloro, Alfred C. O. Vertegaal, Ugo Mayor, Felix Elortza, Simona Polo, Rosa Barrio y James D. Sutherland.
28. THE RBPOME OF INFLUENZA A VIRUS MRNA REVEALS A ROLE FOR TDP-43 IN VIRAL REPLICATION. Matondo Mariette.
POSTERS COMMUNICATIONS.
29. THE ROLE OF GLUCOSAMINE 6 PHOSPHATE ISOMERASE 2 (GNPDA2) IN NEURODEGENERATION BY -OMICS. Mercedes Lachén-Montes, Paz Cartas-Cejudo, Adriana Cortés, Elena Anaya-Cubero, Joaquín Fernández-Irigoyen y Enrique Santamaría.
30. PROTEOMIC CHARACTERIZATION OF THE HUMAN TAU P301L ZEBRAFISH LARVAE. Mercedes Lachén-Montes, Paz Cartas-Cejudo, Adriana Cortés, Elena Anaya-Cubero, Karina Ausín, Erika Peral, Ramón Díaz, Joaquín Fernández-Irigoyen y Enrique Santamaría.
31. BEATBOX AND IST FOR STANDARDIZED FFPE TISSUE PROCESSING: A ROBUST, HIGH-THROUGHPUT, XYLENE-FREE SAMPLE PREPARATION FOR PROTEOMIC ANALYSIS. Quentin Enjalbert.
33. UNRAVELLING THE ROLE OF CANDIDA ALBICANS PRN1 IN THE OXIDATIVE STRESS RESPONSE THROUGH A PROTEOMIC APPROACH. Víctor Arribas, Lucía Monteoliva, Concha Gil y Gloria Molero.
34. DEVELOPMENT OF PTMSCAN-HS IMMUNOAFFINITY REAGENTS AND STANDARDS FOR PTM ENRICHMENT: HIGH SENSITIVITY, HIGH SPECIFICITY, HIGHLY SIMPLIFIED, AND HIGH THROUGHPUT. Maxime Jacquet, Alissa J. Nelson, Hayley Peckham, Michael Palazzola, Charles L. Farnsworth, Kathryn Abell, Antohny Possemato, Mukesh Kumar, Kimberly A. Lee y Matthew P. Stokes.
35. RENEWED MASS SPECTROMETRY-BASED PROTEOMICS: SPEEDING UP AND GETTING DEEPER. Ibon Iloro, Mikel Azkargorta, Iraide Escobés, Jabier Beaskoetxea y Félix Elortza.
36. PROXIMITY EXTENSION ASSAY (PEA), A CUTTING-EDGE PROTEOMICS TECHNOLOGY: ENHANCING MOLECULAR PROFILING AND TAILORED CLINICAL CARE FOR RHEUMATIC DISEASES THROUGH. Yas Hanaee, Beatriz Vellón García, Adrián Llamas Urbano, Clementina López-Medina, Julio Manuel Martinez-Moreno, Iván Arias-de la Rosa, María Angeles Aguirre, Eduardo Collantes, Alejandro Escudero-Contreras, Chary López-Pedrera, Carlos Pérez-Sanchez y Nuria Barbarroja.
37. PARAMETER OPTIMIZATION FOR A ROBUST SINGLE-CELL ANALYSIS WORKFLOW. María Luz Valero Rustarazo, Oreto Antúnez Temporal, Armand Congost Maestre, Laura Cantero González-Salazar, Sandra Norte Pinto y Manuel M. Sánchez del Pino.
38. SINGLE CELL PROTEOMICS TO ANALYZE ADULT CARDIOMYOCYTES POPULATIONS. Consuelo Marín-Vicente, Cristina Villa del Campo, Rocío Sierra, Enrique Calvo, José Manuel Rodríguez-Carrasco, Akos Végvári, Roman Zubarev, Miguel Torres y Jesús Vázquez.
39. SPATIAL PROTEOMICS DEMONSTRATES CONCENTRIC PROGRESSION OF TUMOR TISSUE CAUSED BY GERMLINE MUTATION IN FH GENE. Laura Cantero González-Salazar, María Luz Valero Rustarazo, Oreto Antúnez Temporal, Armand Congost Maestre, Lara Navarro Cerveró, Vicente Sabater Marco, Raquel Rodríguez-López y Manuel M. Sánchez del Pino.
40. PROTEOMIC MOLECULAR IMAGING OF MUSSELS FOR ENVIRONMENTAL DIAGNOSIS. Ana María Herruzo-Ruiz, Marina Barbudo-Lunar, Chiara Trombini, Julián Blasco, Carmen Michán, José Alhama y Eduardo Chicano-Gálvez.
41. EARLY, SEX-DEPENDENT AND PROGRESSIVE PROTEOMIC IMBALANCE IN THE AMYGDALA DURING ALZHEIMER´S DISEASE EVOLUTION. Mercedes Lachén-Montes, Jorge Dominguez, Paz Cartas-Cejudo, Adriana Cortés, Elena Anaya-Cubero, Naroa Mendizuri, Karin Ausin, Erika Peral, Ramón Díaz, Isidro Ferrer, Joaquín Fernández-Irigoyen y Enrique Santamaría.
42. A REFERENCE MAP OF EXTRA-CELLULAR VESICLES PROTEIN CARGO. Julia Morales, Joanes Etxeberria, Fernando Garcia, Eduardo Zarzuela, Pilar Ximénez de Embún, Héctor Peinado y Javier Munoz.
43. SEX-DEPENDENT NEUROPROTEOMIC ANALYSIS OF THE PRECUNEUS DURING ALZHEIMER?S DISEASE PROGRESSION. Paz Cartas-Cejudo, Mario Sanz, Mercedes Lachén-Montes, Adriana Cortés, Elena Anaya-Cubero, Karina Ausín, Erika Peral, Ramón Díaz, Isidro Ferrer, Joaquín Fernández-Irigoyen y Enrique Santamaría.
44. SEX-DIVERGENT EFFECTS ON THE NAD -DEPENDENT DEACETYLASE SIRTUIN SIGNALING ACROSS THE OLFACTORY? ENTORHINAL? AMYGDALOID AXIS IN ALZHEIMERS AND PARKINSONS DISEASES. Paz Cartas-Cejudo, Mercedes Lachén-Montes, Joaquín Fernández-Irigoyen y Enrique Santamaría.
45. OLFACTORY BULB PROTEOMICS REVEALS EARLY MOLECULAR ALTERATIONS IN A RAT MODEL OF PROGRESSIVE DOPAMINERGIC DEATH, GUIDING FOR POTENTIAL SERUM BIOMARKERS IN PARKINSON´S DISEASE. Mercedes Lachén-Montes, Paz Cartas-Cejudo, Naroa Mendizuri, Ana Quiroga-Varela, Joaquín Fernández-Irigoyen, Mari Cruz Rodríguez-Oroz y Enrique Santamaría.
46. OLFACTORY PROTEOMICS ACROSS LIMBIC AND NEOCORTICAL NEUROPATHOLOGICAL STAGES IN HUMAN PARKINSON?S DISEASE. Paz Cartas-Cejudo, Mercedes Lachén-Montes, Adriana Cortés, Elena Anaya-Cubero, Marina De Miguel, Karina Ausín, Erika Peral, Ramón Díaz, Joaquín Fernández-Irigoyen y Enrique Santamaría.
47. QUALITATIVE PROTEOMIC ANALYSIS OF ACUTE INFLAMMATION MODELS: LPS AND FAECAL SUSPENSION INTRAPERITONEAL TREATMENT IN MICE. Alejandra Delgado Sequera, Irene Blázquez García, Eduardo López Collazo, Javier Fernandez-Felipe, Francisco Javier Cueto y Fernando J Corrales.
48. UNVEILING SEX BIAS IN PROTEOME AND (PHOSPHO)PROTEOME PROFILE OF PBMCS FROM HEALTHY PATIENTS. Adriana Cortés Jiménez, Paz Cartas-Cejudo, Mercedes Lachén-Montes, Elena Anaya-Cubero, Karina Ausín, Erika Peral, Ramón Díaz, Joaquín Fernández-Irigoyen y Enrique Santamaría.
50. QUANTITATIVE PROTEOMICS IDENTIFICATION OF NOVEL DYSREGULATED PROTEINS IN ALZHEIMER?S DISEASE PATIENTS AS BLOOD-BASED BIOMARKERS OF THE DISEASE AND RELATED TO AMYLOID-? Ana Montero-Calle, Raquel Coronel, Vivian de los Ríos, Alberto Peláez-García, María Jesús Fernández-Aceñero, Javier Martínez-Useros, Isabel Liste, Marta L. Mendes y Rodrigo Barderas.
51. ROAD TOWARDS A FUTURE CANCER VACCINE: ESTABLISHING A METHODOLOGY FOR MICROPROTEIN AND LIGANDOME ANALYSIS OF TUMORAL CELL LINES. Ramon Diaz Peña, Patrick Theunissen, Amaya Abad, Karina Ausin, Erika Peral, Mercedes Lachén-Montes, Paz Cartas-Cejudo, Adriana Cortés Cortés, Enrique Santamaría, Pablo Sarobe, Puri Fortes y Joaquín Fernández-Irigoyen Fernández-Irigoyen.
52. ADAPTATION OF PLASMA-ENRICHMENT STRATEGIES FOR FAST AND SENSITIVE ANALYSIS OF CEREBROSPINAL FLUID. Eva Borrás, Federica Anastasi, Olga Pastor, Marc Suárez-Calvet y Eduard Sabidó.
53. AGING-LINKED OXIDATIVE STRESS SHOWS ABILITY TO IMPACT SERINE PHOSPHORYLATION-MEDIATED CELL SIGNALING. Jose Antonio Sánchez Milán, María Fernández-Rhodes, Julia Lisa, Aida Serra y Xavier Gallart-Palau.
54. LONG NON-CODING RNA-ENCODED PEPTIDES FOUND IN BRAIN EXTRACELLULAR VESICLES LINKED TO SPECIFIC PROFILES THROUGHOUT THE PROGRESSION OF ALZHEIMER?S DISEASE. María Mulet, Cristina Lorca, Julia Lisa, Xavier Gallart-Palau y Aida Serra
55. PROTEOMIC LABEL FREE QUANTITATIVE ANALYSIS OF HUMAN SYNOVIAL FLUID IDENTIFIED NOVEL BIOMARKERS RELATED WITH OSTEOARTHRITIS SEVERITY. Patricia Fernández-Puente, Rocío Paz-González, Valentina Calamia, Florencia Picchi, Patricia Quaranta, Lucía Lourido, Selva Riva Mendoza, Pablo Dominguez-Gerrero, Martin K Lotz, Cristina Ruiz-Romero y Francisco J Blanco.
56. URINARY PROSTATE-SPECIFIC ANTIGEN GLYCAN CHARACTERIZATION. Mikel Azkargorta, Isabel García, Ibon Iloro, Jabi Beaskoetxea, Iraide Escobés, Pablo Valera-Sapena, Laura Armero, Luis Liz-Marzán, Jesús Jimenez-Barbero y Felix Elortza.
57. HOW TO TACKLE PLASMA PROTEOMICS IN A FAST AND COST-EFFECTIVE WAY: COMPARISON OF ABUNDANT PROTEIN DEPLETION METHODS. Jabier Beaskoetxea, Ibon Iloro, Iraide Escobés, Mikel Azkargorta y Felix Elortza.
58. APPLICATION OF PROTEOMICS AND METABOLOMICS FOR EARLY DETECTION AND STAGING OF LUNG CANCER PATIENTS USING HUMAN SPUTUM SAMPLES. Fernando Garrido-Muñoz, María del Sol Arenas-De Larriva, Bernabé Jurado-Gámez, Ignacio Ortea y Alejandro Fernández-Vega
59. MOLECULAR CHANGES IN ENDOTHELIAL COLONY FORMING CELLS EXPOSED TO A DIABETIC ENVIRONMENT. Josefa Benítez Camacho, Antonio Ballesteros Ribelles, Ismael Sánchez Gomar, Marta Rojas Torres, Sara Eslava Alcón, Francisco Rodríguez Martín, María Jesús Extremera García, Lucía Beltrán Camacho, Jorge Cabaña Penagos, Esther Doiz y María del Carmen Durán Ruíz.
60. PROTEOMIC ANALYSIS OF EPCS FROM DIABETIC PATIENTS WITH VASCULAR COMPLICATIONS. Francisco Rodríguez Martin, Josefa Benítez Camacho, Antonio Ballesteros Ribelles, Ismael Sánchez Gomar, Marta Rojas Torres, Sara Eslava Alcón, María Jesús Extremera García, Lucía Beltrán Camacho, Jorge Cabañas Penagos, Esther Doiz y María Carmen Durán Ruíz.
61. IDENTIFICATION OF PROTEOMIC SERUM BIOMARKERS IN ATHEROSCLEROSIS. M. Jesús Extremera-García, Marta Rojas-Torres, Sara Eslava-Alcón, Francisco Rodriguez-Martín, Blanca Priego, Josefa Benitez-Camacho, Antonio Ballesteros, Ana Martinez del Val, Jesper Olsen, Eva Lozano-Loaiza, Esther Doiz y MCarmen Durán-Ruiz.
62. ALTERATION OF PROTEOMIC PROFILE IN PATIENTS WITH PSORIASIS AND SUBCLINICAL ATHEROSCLEROSIS AND THE USE OF BIOLOGICAL THERAPY: ATHERORISKPSO PROJECT. Ines Perales-Sanchez, Nerea Corbacho-Alonso, Tamara Sastre-Oliva, Cristina Juarez-Alia, German Hernandez-Fernandez, Montserrat Carrascal, Alvaro Gonzalez-Cantero, Laura Mourino-Alvarez y Maria G. Barderas.
63. ALZHEIMER AND CARDIOVASCULAR DISEASE: UNRAVELING THEIR CONNECTION THROUGH THE STUDY OF THE PROTEOME. Cristina Juarez-Alia, Tamara Sastre-Oliva, Nerea Corbacho-Alonso, Ines Perales-Sanchez, German Hernandez-Fernandez, Eduardo Chicano-Galvez, Felipe Madruga, Laura Mourino-Alvarez y Maria G Barderas.
64. MOLECULAR INSIGHTS OF CHOLESTASIS IN MDR2KO MURINE LIVER ORGANOIDS. A MODEL FOR THE EARLY DETECTION OF CIRRHOSIS AND HCC. Irene Blázquez-García, Laura Guerrero, Cristina Cacho-Navas, Nabil Djouder, Jaime Millan, Lorena Carmona-Rodríguez y Fernando J. Corrales.
65. MOLECULAR CHANGES ASSOCIATED TO ISCHEMIA AND CELL THERAPY ADMINISTRATION IN A MURINE MODEL OF CRITICAL LIMB-THREATENING ISCHEMIA. Marta Rojas-Torres, Ana Martínez-Val, Lucía Beltrán-Camacho, Sara Eslava-Alcón , Ismael Sánchez-Gomar, Antonio Rosal-Vela, Margarita Jiménez-Palomares, Mario Martínez-Torrija, Rafael Moreno-Luna, Jesper V. Olsen y Maria del Carmen Durán-Ruíz.
66. UNCOVERING THE POTENTIAL OF BOTTOM-UP PROTEOMICS FOR BRONCHOPULMONARY DYSPLASIA IN PRETERM INFANTS BORN BEFORE 30 WEEKS OF GESTATION. Fernando Garrido-Muñoz, Alejandro Fernández-Vega y Almudena Alonso-Ojembarrena.
67. REDOX STATUS CHARACTERISATION OF TUMOUR TISSUE FROM PSEUDOMYXOMA PERITONEI PATIENTS. Florina Iulia Bura, María Torres Martínez, Melissa Granados Rodríguez, Mari Carmen Vázquez Borrego, Francisca Valenzuela Molina, Blanca Rufián Andújar, Ana Moreno Serrano, Laura Morón Márquez, Carmen Michán, José Alhama, Álvaro Arjona Sánchez y Antonio Romero Ruiz.
68. GLOBAL OXIDATIVE POSTTRANSLATIONAL MODIFICATIONS IN THE HEART AFTER ISCHEMIA-REPERFUSION INJURY. Inmaculada Jorge, Aleksandra Binek, Celia Castans, Navratan Bagwan, José Manuel Rodríguez, Rodrigo Fernández-Jiménez, Carlos Galán-Arriola, Eduardo Oliver, Agustín Clemente-Moragón, Borja Ibanez, Emilio Camafeita y Jesús Vázquez.
69. A PROTEOMIC STUDY TO EXPLORE THE POTENTIAL OF ANTI-CYTOKINE AUTOANTIBODIES FOR PREDICTING FLARE EPISODES IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH BIOLOGIC THERAPIES. Pablo Domínguez Guerrero, Patricia Quaranta, Rocío Paz González, Juan D Cañete, Benjamín Fernández Gutiérrez, Isidoro González Álvaro, Jose Luis Pablos, Natividad Oreiro, Belén Acasuso, Francisco J Blanco, Cristina Ruiz Romero y Lucía Lourido.
70. APPLICATION OF PROTEOMICS STRATEGIES IN THE DISCOVERY AND QUANTIFICATION OF SALIVARY BIOMARKERS FOR EQUINE METABOLIC SYNDROME. Elisa María Espinosa-López, Emily Clarke, Beatriz Ortiz, Elisa Diez de Castro, Mandy Peffers, Escolástico Aguilera-Tejero y Guadalupe Gómez-Baena.
71. LABELFREE PROTEOMICS TO UNCOVER THE ANTI- CANDIDA EFFECT OF METFORMIN. Victoria Mascaraque, Celia Pozo, Cristina Navas, María Luisa Hernáez, Concha Gil y Gloria Molero.
72. CHARACTERIZATION OF HEPATIC DAMAGE IN MICE WITH SICKLE CELL DISEASE BY A LABEL FREE QUANTITATIVE PROTEOMIC APPROACH. Lucía Beltrán Camacho, Mercedes Vallejo Mudarra, Isabel Pozuelo Sánchez, Cristina García Caballero, Raquel María García Sáez, Lucía Sánchez Arcas, Marta Rojas Torres, María del Carmen Durán Ruiz y Juan Antonio Moreno Gutiérrez.
73. QUANTITATIVE PROTEOMICS REVEALS THAT SARS-COV-2 ORF7A IMPAIRS CELLULAR METABOLISM IN LUNG EPITHELIAL CELLS. Tránsito García-García, Raúl Fernández-Rodríguez, Blanca D. López-Ayllón, María Montoya y Jua Garrido.
74. PROTEOMIC ANALYSIS OF PLASMA EXTRACELLULAR MICROVESICLES IN THE SEARCH OF BIOMARKERS FOR EQUINE METABOLIC SYNDROME DIAGNOSIS. Beatriz Ortiz Guisado, Elisa María Espinosa López, Carlos Fuentes Almagro, Andy Durham, Escolástico Aguilera Tejero, Elisa Diez de Castro y Guadalupe Gómez Baena.
75. QUANTITATIVE PROTEOMICS ANALYSIS OF CEREBROSPINAL FLUID UNVEILS CANDIDATE PROTEIN BIOMARKERS FOR CANINE NON-INFECTIOUS MENINGOENCEPHALOMYELITIS. Mercedes Aradillas-Pérez, Elisa María Espinosa-López, Alejandro Seisdedos-Benzal , Alba Galán-Rodríguez y Guadalupe Gómez-Baena.
76. PRE-EXISTING IMMUNITY EFFECT ON THE PATIENT OUTCOME: CHRONIC LYMPHOCYTIC LEUKEMIA AND SARS-COV-2 INFECTION AS MODEL. Carlota Arias Hidalgo, Pablo Juanes Velasco, Ana Nuño Soriano, Ángela Patricia Hernández y Manuel Fuentes.
77. PROTEOGENOMICS AND IMMUNOPEPTIDOMICS GUIDED THE MOLECULAR CLASSIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA FOR PEPTIDE BASED IMMUNOTHERAPY. Manuel Fuentes.
78. INTEGRATIVE OMICS ANALYSIS OF MALADAPTIVE RIGHT VENTRICULAR HYPERTROPHY IN CHRONIC PULMONARY HYPERTENSION. Emilio Camafeita, Inmaculada Jorge, Inés García-Lunar, Jorge Saiz, Núria Solanes, Juan José Rodríguez-Arias, María Morán, Montserrat Rigol, Coral Barbas, Borja Ibáñez, Jesús Vázquez y Ana García-Álvarez.
79. PROTEOMIC RESPONSE TO DIETARY SUPPLEMENTATION WITH POLYPHENOL-RICH SALICORNIA RAMOSISSIMA EXTRACT IN HEALTHY VOLUNTEERS. Ana M. Nájar, Carmen Del Río, Soledad Pérez Sánchez, Marina Romero Bernal, Ángela González Díaz, Marcel Lmana Vallverdú, Cristin López Azcárate, Carmen Domínguez, Reyes De Torres y Joan Montaner.
80 ENDOMETRIOSIS PROTEOMIC STUDY. Belén López Viñas, Cristina Gullián Maquieira, Sara Quintana Tustain, Cristina Varela Pombo, Mónica Carrera, Concha Gil, Lola Gutiérrez, Juan A. Fafián Labora y María C. Arufe.
81. INNOVATIVE BIOMATERIAL FOR 3D SKIN MODELS: UNRAVELING PROTEIN COMPOSITION THROUGH VARIED EXTRACTION METHODS AND MASS SPECTROMETRIC ANALYSIS OF HUMAN DECELLULARIZED DERMIS-DERIVED EXTRACELLULAR MATRIX SCAFFOLD. Estibaliz Fernandez-Carro, Ana Rosa Remacha , Irene Orera , Giuseppe Lattanzio, Alberto Garcia-Barrios , Jesús del Barrio , Clara Alcaine y Jesús Ciriza.
82. PROTEOMIC ENDOTYPING OF PATIENTS SUFFERING FROM KNEE OSTEOARTHRITIS AND ASSOCIATED COMORBIDITIES. Patricia Quaranta, Patricia Fernández-Puente, Florencia Picchi, Cristina Ruiz-Romero, Lucía Lourido, Rocío Paz-González, Silva Riva-Mendoza, Pablo Domínguez-Guerrero, Francisco Blanco García y Valentina Calamia.
83. PROTEOMIC CHARACTERIZATION OF EXTRACELLULAR VESICLES SECRETED BY CANDIDA ALBICANS: EXPLORING THEIR POTENTIAL UTILITY AS VACCINES AGAINST CANDIDIASIS. Raquel Martínez-López, Matías Cabeza, Claudia Marcela Parra Giraldo, Guillermo Castejón, Luis Felipe Clemente, María Luisa Hernaez, Gloria Molero, Concha Gil y Lucía Monteoliva.
84. ANALYTICAL DEVELOPMENT OF ACINETOVAX VACCINE: EXAMPLE OF PROTEOMIC APPROACHES IN BIOPHARMACEUTICAL DEVELOPMENT. Gustavo Adolfo Sánchez-Corrales.
85. FACTORS IMPACTING T CELL RESISTANCE TO LENTIVIRAL TRANSDUCTION. A PROTEOMIC APPROACH. Ricardo Fernandez-Cisnal, Belén Sierro-Martínez, Estefanía García-Guerrero, Eduardo Chicano-Galvez, Ángela Peralbo-Molina, Cecilia Fernandez-Ponce, Pablo Gonzalez-Garcia, Juan P. Muñoz-Miranda, Noelia Moares, Jose A. Pérez-Simón y Francisco Garcia-Cozar.
86. CHANGES IN HEPATIC PROTEOSTASIS INDUCED BY A MIXTURE OF CONTAMINANTS IN MICE ARE AMELIORATED BY SELENIUM. A PROTEOMIC APPROACH. Paula V. Huertas-Abril, Juan Jurado, M. José Prieto-Alamo, Tamara García-Barrera y Nieves.
87. IMMUNOGENIC CELL DEATH: EVALUATION OF A CHEMOLIBRARY OF NATURAL PRODUCT-DERIVED COMPOUNDS. Ana Nuño Soriano, Carlota Arias Hidalgo, Pablo Juanes Velasco, Angela Patricia Hernández y Manuel Fuentes García.
88. PROFILING THE SURFACEOME AND IMMUNOPEPTIDOME OF EXOSOMES IN AN INFLAMMATORY CONTEXT. Jaxaira Maggi, Daniel Closa, Joaquin Abian y Montserrat Carrascal.
89. DECIPHERING THE ADIPOSE TISSUE PROTEOME IN METABOLICALLY UNHEALTHY LEAN INDIVIDUALS. Rocio Guzmán-Ruiz.
90. ANALYSIS OF SERUM BIOMARKERS TO EVALUATE THE IMPACT OF NEW ANTIRETROVIRAL DRUGS ON THE METABOLIC FUNCTION OF ADIPOSE TISSUE. Maria del Carmen Soler-Vázquez, Samuel Lorenzo-Pino, Rocío Guzmán-Ruíz, Mario Frías, Antonio Rivero-Juárez, Antonio Rivero, María del Mar Malagón y Ana Gordon.
91. EFFECTS OF A DIET SUPPLEMENTED WITH OLIVE POMACE ON THE PROTEIN EXPRESSION OF ZEBRAFISH. Juan Jurado, Paula V. Huertas-Abril, Nieves //00, José Manuel Jiménez-Pastor y María José Prieto-Álamo.
92. PROTEOMICS ANALYSIS OF THE SECRETOME OF MACROPHOMINA PHASEOLINA STRAINS WITH DIFFERENT VIRULENCE. Amiliana Pineda-Fretez, Jazmín Vaceque Acosta, Alberto Cubilla-Rios, Javier Barúa, Maria Eugenia Flores-Giubi, Julio Iehisa y Ma. Cristina Romero-Rodríguez.
93. INTEGRATION OF PROTEOMICS AND METABOLOMICS APPROACHES FOR THE STUDY OF THE RESPONSES TO STRESSES ASSOCIATED TO THE DECLINE SYNDROME AND CLIMATE CHANGE IN HOLM OAK. Tamara Hernández-Lao, Marta Tienda-Parrilla, Mónica Labella-Ortega, Victor M. Guerrero-Sánchez, María-Dolores Rey, Jesús V. Jorrín-Novo y María Ángeles Castillejo Sánchez.
94. IDENTIFICATION OF PROTEINS SECRETED BY MACROPHOMINA PHASEOLINA IN LIQUID MEDIUM WITH AND WITHOUT SOYBEAN LEAF INFUSION. Adriana Orrego, Amiliana Pineda-Fretez, Julio Cesar Masaru Iehisa, Maria Eugenia Flores-Giubi, Javier Barúa, Rosa Sánchez-Lucas, Jesús Jorrín-Novo y María Cristina Romero-Rodríguez.
95. THE ROLE OF B. CINEREA BIOACTIVE PEPTIDES DURING INFECTIVE PROCESS AND ITS APPLICATION AS NEW SOURCE OF BIOACTIVE COMPOUNDS. Almudena Escobar Niño, Francisco Javier Navas López, Mary Selva Cuiñas Diaz y Francisco Javier Fernández Acero.
96. DECIPHERING THE BACTERIAL BIODEGRADATION MECHANISMS OF LOW-DENSITY POLYETHYLENE THROUGH PROTEOMICS. Alfonso Olaya-Abril, Gema Rodríguez Caballero, Karolina A. Bie??o, Purificación Cabello, Lara P. Sáez, Víctor M. Luque-Almagro, Conrado Moreno Vivián y María Dolores Roldán.
97. IDENTIFICATION OF POTENTIAL ALLERGENIC PROTEINS IN QUERCUS ILEX ACORNS USING IN SILICO AND IN VITRO PROTEOGENOMIC APPROACHES. Tamara Hernández Lao, Rosa Rodríguez Pérez, Dolores Rey María, Jesús Jorrín Novo, María Angeles Castillejo Sánchez.
99. GENOME-WIDE IDENTIFICATION AND EXPRESSION ANALYSIS OF THE SUBTILISIN-LIKE PROTEASE GENE FAMILY IN QUERCUS ILEX. Daniela Hernández-Hernández, María-Dolores Rey, María-Ángeles Castillejo y Jesús V. Jorrín-Novo.
100. EXTRACTION OF MICROBIAL PROTEINS FROM COMPLEX SAMPLES: A BOTTLENECK FOR THE FUNCTIONAL PROTEOMIC ANALYSIS OF RELEVANT ENVIRONMENTAL AND CLINICAL ISSUES. Marina Barbudo-Lunar, Chiara Trombini, Florina Iulia Bura, Rafaela Rocha Pezzopane, Mari Carmen Vázquez-Borrego, Julián Blasco, Antonio Romero-Ruiz, Carmen Michán y José Alhama.
101. IDENTIFICATION AND CHARACTERIZATION OF BIOACTIVE PEPTIDES IN QUERCUS ILEX ACORNS AS A FOOD SOURCE WITH NUTRITIONAL AND NUTRACEUTICAL VALUE. Tamara Hernández-Lao, Nieves Casillas Ruiz, Abraham Vidal-Limón, Eliel Ruiz-May, Marta Tienda-Parrilla, Mónica Labella-Ortega, Ana M. Maldonado-Alconada, Jesús V. Jorrín-Novo y María Ángeles Castillejo-Sánchez.
102. IDENTIFICATION OF PROTEINS INVOLVED IN THE RESPONSE OF STRAWBERRY PLANT LEAF TISSUE TO DROUGHT. María Dolores Moreno Recio, Sara Aguado Delgado, José Ángel Mercado, Sara Posé, José Luis Caballero, Enriqueta Moyano, Francisco Javier Molina Hidalgo, Juan Muñoz Blanco, M Ángeles Castillejo Sánchez y Rosario Blanco Portales.
103. THE BIOSYNTHESIS OF PHENYLPROPANOIDS AND ABA IN STRAWBERRY PLANT ROOTS APPEARS TO BE AFFECTED BY AMBIENT RELATIVE HUMIDITY. Sara Aguado Delgado, María Dolores Moreno Recio, José Ángel Mercado, Sara Posé, José Luis Caballero, Enriqueta Moyano, Francisco Javier Molina Hidalgo, Juan Muñoz Blanco, Rosario Blanco Portales y M Ángeles Castillejo Sánchez.
104. QSAMPLE: A QUALITY CONTROL SYSTEM TO MONITOR USER?S SAMPLES IN PROTEOMICS CORE FACILITIES. Cristina Chiva, Roger Olivella, Roger Olivella y Eduard Sabidó.
105. PTM STRUCTURE VIEWER (PSV): A NEW TOOL FOR CHARACTERIZING POST-TRANSLATIONAL MODIFICATIONS IN PROTEIN STRUCTURES. Diego Mena-Santos, Emilio Camafeita, Estefanía Nuñez, David del Río Aledo, José Manuel Rodríguez, Cristina Amparo Devesa-Arbiol, Inmaculada Jorge, Juan Miguel Redondo y Jesús Vázquez.
106. ISANXOT: A STANDALONE APPLICATION FOR THE INTEGRATIVE ANALYSIS OF MASS SPECTROMETRY-BASED QUANTITATIVE PROTEOMICS DATA. Jose Manuel Rodríguez, Inmaculada Jorge, Emilio Camafeita y Jesús Vázquez.
107. TO BE OR NOT TO BE: HOW DO DIFFERENT NORMALIZATIONS CHANGE OUR RESULTS IN RELATIVE PROTEOME QUANTIFICATION. Julia García Currás, María P. Pata, Susana Belén Bravo, Manuela Alonso-Sampedro, Guillermo L. Taboada y Francisco Gude.
108. A NOVEL BIOINFORMATICS WORKFLOW FOR UNBIASED ANALYSIS OF POSTTRANSLATIONAL MODIFICATIONS: APPLICATION TO SUBCLINICAL ATHEROSCLEROSIS. Cristina Devesa-Arbiol, Inmaculada Jorge Cerrudo, Emilio Camafeita, Estefanía Núñez, Elena Bonzón-Kulichenko, Jose Manuel Rodríguez, Andrea Laguillo, Rafael Barrero, Jose Luis Martín-Ventura y Jesús Vázquez.
109. THE IMPORTANCE OF A PROPER EXPERIMENTAL DESIGN AND AN STREAMLINED QUALITY CONTROL FOR DIFFERENTIAL ABUNDANCE ANALYSIS. Ignasi Folch-I-Casanovas, Gianluca Arauz-Garofalo, Mar Vilanova, Mireia Diaz-Lobo, Carla Triguero, Sonia Jario, Laura Villarreal, Antonia Odena, Marina Gay y Marta Vilaseca.
110. THE IMPORTANCE OF A PROPER EXPERIMENTAL DESIGN AND AN STREAMLINED QUALITY CONTROL FOR DIFFERENTIAL ABUNDANCE ANALYSIS. Ignasi Folch-I-Casanovas, Gianluca Arauz-Garofalo, Mar Vilanova, Mireia Diaz-Lobo, Carla Triguero, Sonia Jario, Laura Villarreal, Antonia Odena, Marina Gay y Marta Vilaseca.
111. UNDERSTANDING FERTILITY CHALLENGES IN DONKEYS IN COMPARISON TO MARES BY CONDUCTING A COMPARATIVE PROTEOMIC ANALYSIS OF ENDOMETRIAL TISSUE AND UTERINE EXUDATE. Beatriz Ortiz Guisado, Rafaela Herrera García, Manuel Hidalgo Prieto, Jesús M. Dorado Martín, Isabel Ortiz Jaraba, Guadalupe Gómez Baena.
112. DEEPER PLASMA PROTEOME COVERAGE ENABLES IDENTIFICATION OF NOVEL BIOMARKERS AND CLASSIFICATION OF DISEASES. Katrin Hartinger, Christopher Below, Andreas Schmidt, Zehan Hu, Claudia Martelli, Katharina Limm, Xaver Wurzenberger, Beatriz Rocha, Pedro Cano, Verena Tellstroem, Roland Bruderer, Jonathan Moss.
113. SPATIALOMX USING SUPERVISED SEGMENTATION ANALYSIS GUIDE IN-DEPTH PROTEOMIC CHARACTERIZATION AND SUBTYPING OF CARDIAC AMYLOIDOSIS. Juliane Gottwald, Corina Henkel, Romano Hebeler, Janina Oetjen, Beatriz Rocha, Pedro Cano, Christian Treitz, Andreas Tholey, Christoph Röcken.
114. EVOLUTION OF SOLUBLE MUSCLE PROTEOME IN NORMAL AND DEFECTIVE BOVINE MEATS DURING AGEING. Daniel Alegre, Enrique Sentandreu, Verónica Sierra, Miguel Ángel Sentandreu.
115. PEPTIDOMIC AND METAGENOMIC ANALYSIS OF GOAT MILK KEFIR. Johan Alejandro Álvarez Satizábal, Manuel J. Rodriguez Ortega.
